ARL11 and prostate carcinoma: Researchers have demonstrated that ARL11 variants may contribute to the familial risk of various cancer types, such as chronic lymphocytic leukemia, melanoma, breast cancer, prostate cancer, colorectal cancer, and ovarian cancer [16, 33–36].